About Manisha Chatterjee

Since she was young, Manisha has had a strong interest in the stock market. She majored in Economics in college and has a passion for writing, which has led to her career as a research analyst. Manisha’s goal is to help individual investors succeed in the stock market. She uses her knowledge in fundamental analysis to evaluate companies and determine if they are worthwhile investments.


Recent Articles By Manisha Chatterjee

: NEE |  News, Ratings, and Charts

NextEra Energy: Buy, Sell, or Hold?

NextEra Energy (NEE) is expected to generate significant returns over the long term because governments around the world are pushing for greater use of renewable energy to tackle the growing threat of climate change. However, is it worth buying the stock at its current valuation? Read on.
: HLF |  News, Ratings, and Charts

Can Herbalife Bounce Back in 2021?

Even though there have been several controversies surrounding Herbalife’s (HLF) marketing model over the years, its core operations and distribution lend the company a competitive advantage. And with consumer interest in health and wellness on the ascent, HLF is expected to witness increasing demand for its products. So, let’s take a closer look at this company’s prospects now.
: XM |  News, Ratings, and Charts

Will Qualtrics Keep Losing in 2021?

Qualtrics (XM), which is known for its unique experience management platform, had an impressive stock market debut on January 28. But the stock has been on a downtrend since. However, an important question now is will its recent partnership with IBM Japan help it generate significant returns this year? Let’s find out.
: PINS |  News, Ratings, and Charts

After Plunging More Than 10% Last Week, is Pinterest a Buy?

Pinterest (PINS) is an established company in the social media space that is known for its virtual Pinboard style, which attracts millions of users worldwide. However, the company’s stock price fell sharply following an unfavorable comment by a Cleveland Research analyst. So, let’s find out if PINS is set for a rebound or if it faces more trouble down the road.
: NTR |  News, Ratings, and Charts

A Top Agriculture Stock to Add to Your Portfolio

Canada-based agricultural chemicals company Nutrien (NTR) has generated significant returns by leveraging its diverse portfolio of products and services in the agriculture space. Because the industry appears to be on the path to recovery from the pandemic-driven recession, with increasing crop prices, we think it’s wise to bet on the stock now. Let’s take a closer look at NTR.
: WKHS |  News, Ratings, and Charts

Workhorse Plunges More Than 40% in 2021: More Downside Left?

The price of Workhorse’s (WKHS) shares has been declining since late February when the company lost out on a Next Generation Delivery Vehicle (NGDV) contract with the United States Postal Service (USPS). So, let’s find out if this was only a bump in the road for the EV and drone system company or if it is expected to continue going downhill from here. Read on.
: PDCE |  News, Ratings, and Charts

Is PDC Energy a Great Energy Stock Right Now?

PDC Energy (PDCE) has been growing organically and inorganically over the past few months. And given rising oil prices, we think the company should continue to increase its revenues. So, it could be wise to bet on the stock now. Read on
: ILMN |  News, Ratings, and Charts

Illumina is a Buy Even After the Recent Sell-Off

Illumina (ILMN) has grown significantly over the past few months on huge demand for its products and services in the genetic analysis space. And although its share price has dipped since the FTC announced that it will challenge ILMN’s proposed acquisition of Grail, the stock is expected to regain its rally soon given the company's numerous strategic alliances. Read on for details.
: TMDI |  News, Ratings, and Charts

Is Titan Medical a Good Medical Equipment Stock to Add to Your Portfolio?

Toronto-based Titan Medical (TMDI) is a small company in the growing medical robotic equipment space. The company is developing its Enos system—a potentially new standard of care in robotic single access surgery. But should investors scoop up its shares at this stage? Let’s find out.
: ZM |  News, Ratings, and Charts

Will Zoom Video Keep Losing in 2021?

Zoom (ZM) became synonymous with remote conferencing last year as COVID-19 lock-down restrictions made the service a group-communications go-to. The stock thus enjoyed immense investor attention. However, given the extensive vaccination drives so far this year, many organizations may now be considering a resumption of physical conferences at the expense of virtual ones. Also, major tech companies are now offering similar services. So, the question is, will ZM be able to regain its momentum this year?
Page generated in 0.7709 seconds.